Free Trial

Science 37 (SNCE) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Science 37 - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 2 Analyst Ratings

Consensus Price Target

N/A

TypeCurrent Forecast
5/23/23 to 5/22/24
1 Month Ago
4/23/23 to 4/22/24
3 Months Ago
2/22/23 to 2/22/24
1 Year Ago
5/23/22 to 5/23/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
4 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/A$20.00$70.00
Forecasted UpsideN/AN/A265.10% Upside175.69% Upside
Get Science 37 Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SNCE and its competitors with MarketBeat's FREE daily newsletter.

SNCE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SNCE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Science 37 Stock vs. The Competition

TypeScience 37Medical CompaniesS&P 500
Consensus Rating Score
2.00
2.69
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside705.76% Upside8.68% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/30/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Neutral
1/29/2024Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
11/14/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Smock
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
11/14/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$140.00 ➝ $60.00+252.94%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:00 PM ET.

SNCE Frequently Asked Questions

What is Science 37's purchase recommendation?

According to the research reports of 2 Wall Street equities research analysts, The consensus rating for Science 37 stock is Hold based on the current 2 hold ratings for SNCE. Learn more on SNCE's analyst rating history.

Do Wall Street analysts like Science 37 more than its competitors?

Analysts like Science 37 less than other "medical" companies. The consensus rating for Science 37 is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SNCE compares to other companies.


Stock Forecasts and Research Tools

This page (NASDAQ:SNCE) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners